Mckesson Corp (MCK)

Cencora has trailed the S&P 500 index over the past year, but analysts remain highly bullish about the stock’s prospects.

LeAnn B Smith, the EVP & Chief HR Officer of $MCK ($MCK), sold 579 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 28.6% of...

Although McKesson has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

McKesson has exceeded the broader market's performance over the past year, and Wall Street analysts are highly positive about the stock's outlook.

McKesson Corporation’s MCK dedicated business focused on supporting the commercialization of cell and gene therapies, InspiroGene, has been selected by Vertex Pharmaceuticals Incorporated VRTX to expand...

While established healthcare firms are among the most stable stocks in the sector, up-and-coming companies can offer the potential for greater gains.

Most U.S. stocks rose as the Federal Reserve cut interest rates again to make things easier for the economy

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed unchanged, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.54%. Stocks on Thursday...

The S&P 500 Index ($SPX ) (SPY ) today is up +0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.22%. Stocks today are moderately higher,...

The S&P 500 Index ($SPX ) (SPY ) today is up +0.36%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.84%. Stocks today are moderately higher,...